| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | -1.6% |
| R&D Expense | $3.3M | -5.9% |
| SG&A Expense | $3.4M | -4.1% |
| Operating Income | -$4.2M | +6.9% |
| Income Tax | $0 | — |
| Net Income | -$4.0M | +4.2% |
| EPS (Basic) | -$2.57 | +5.2% |
| EPS (Diluted) | -$2.57 | +5.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $6.6M | -31.3% |
| Total Assets | $6.9M | -34.9% |
| Current Liabilities | $894K | +10.5% |
| Total Liabilities | $894K | +10.5% |
| Stockholders' Equity | $6.0M | -38.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | +31.5% |